Fulgent Genetics, Inc. Overview
Pro stress-test →Fulgent Genetics is a clinical laboratory and molecular diagnostics company providing genetic testing and sequencing services. The company offers comprehensive genomic analysis for rare disease diagnosis, oncology, and prenatal testing, serving healthcare providers and patients across multiple therapeutic areas.
Strategic Profile
Pro stress-test →Fulgent differentiates through high-throughput sequencing capabilities and direct-to-consumer offerings alongside clinical partnerships. The company has expanded beyond rare disease diagnostics into oncology and infectious disease testing, positioning itself as an integrated genomics platform with competitive cost structures.
Competitive Landscape
Pro stress-test →Fulgent competes with larger clinical laboratory networks like LabCorp and Quest Diagnostics, specialized genomics companies like Invitae and Myriad Genetics, and emerging direct-to-consumer genetic testing providers. The company differentiates through proprietary sequencing technology and cost-competitive testing models.
Industry Context
Fulgent Genetics, Inc. operates in Clinical Laboratory Services / Genomic Diagnostics.
Key facts
Founded: 2011 · Headquarters: Temple City, California · Employees: 1,200 · Revenue: $450M · Market cap: $1.2B